Prevalence of Vaginal Candidiasis and Determination of the Occurrence of Candida Species in Pregnant Women Attending the Antenatal Clinic of Thika District Hospital, Kenya

Menza Nelson, Wanyoike Wanjiru, Muturi W. Margaret

Department of Botany, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
Department of Medical Laboratory Sciences, Kenyatta University, Nairobi, Kenya.

DOI: 10.4236/ojmm.2013.34040                

Abstract

Epidemiological monitoring of vaginal candidiasis infections associated with preterm delivery and death of the infant is highly desirable especially in pregnant women. The objectives were to determine the prevalence of vaginal candidiasis and the occurrence of Candida species in pregnant women attending the antenatal clinic of Thika District Hospital, Kenya. Vaginal swabs were collected from 104 pregnant women between the months of June and August 2010. The Candida species were identified by standard mycological and biochemical methods and the prevalence was determined by , where: O is the number of individuals with the disease and P is the total number of individuals in the population involved in the study. Out of 104 samples obtained from the pregnant women with symptoms of vaginal candidiasis, 94 (90.38%) patients were tested positive and 10 (9.62%) were tested negative for vaginal candidiasis. The percentage distribution of vaginal candidiasis within age group was highest in the age brackets 26 - 35 years with 56(60%) patients and in the 3^rd trimester of pregnancy with 64(68.09%) patients. The percentage occurrence of vaginal Candida species showed that Candida albicans was the most isolated species with 60(63.83%) isolates. The results indicated a high prevalence of vaginal candidiasis: 42.7%. The women at great risk were those between 26 - 35 years and in their 3^rd trimester. Candida albicans was the most prevalent vaginal Candida species across all age groups and trimesters.

Keywords

Vaginal Candidiasis; Occurrence of Candida Species; Pregnant Women

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	R. Kaufman, “Vulvovaginal Candidiasis: A Symposium,” Journal of Reproductive Medicine, Vol. 31, No. 7, 1986, pp. 639-672.
[2]	M. Gonzalez, M. Elizondo and J. Ayala, “Trends in Species Distribution and Susceptibility of Blood stream Isolates of Candida collected in Monterrey Mexico to Seven Antifungal Agents,” Journal of Clinical Microbiology, Vol. 46, No. 9, 2008, pp. 2902-2905. http://dx.doi.org/10.1128/JCM.00937-08
[3]	H. Mitchell, “Vaginal Discharge-Causes, Diagnosis and Treatment,” Biomedical Journal, Vol. 328, 2004, pp. 1306-1308.
[4]	C. Carrol, R. Hurley and V. Stanley, “Criteria for Diagnosis of Candida Vulvovaginitis in Pregnant Women,” Journal of Obstetrics and Gynecology of the British Commonwealth, Vol. 80, No. 3, 2003, pp. 258-263. http://dx.doi.org/10.1111/j.1471-0528.1973.tb02195.x
[5]	J. Sobel, “Vaginitis,” New England Journal of Medicine, Vol. 337, No. 26, 1997, pp. 1896-1903. http://dx.doi.org/10.1056/NEJM199712253372607
[6]	G. Monif, “Diagnosis of Infectious Vulvovaginal Disease,” Infectious Medicine, Vol. 18, 2001, pp. 532-533.
[7]	J. Chander, “A Textbook of Medical Mycology,” 2nd Edition, Mehta Publishers, New Delhi, 2002, pp. 212- 227.
[8]	F. Baker, “Handbook of Bacteriological Technique,” 2nd Edition, Butterworth Co. Ltd., London, 1967, pp. 415- 421.
[9]	J. Lodder (Ed.), “The Yeasts,” North-Holland Publishing Co., Amsterdam, 1970, pp. 200-210.
[10]	S. Sehgal, “Epidemiology of male Urithritis in Nigeria,” Journal of Tropical Medicine Hygiene, Vol. 93, 1990, pp. 151-152.
[11]	F. Okungbowa, O. Isuehuemhen, and A. Dede, “The Distribution, Frequency of Candida Species in the Genitourinary Tract among Symptomatic individuals in Nigeria cities,” Revised Iberoam Microbiology, Vol. 20, 2003, pp. 60-63.
[12]	E. Akortha, O. Chikwe and O. Nwaugo, “Antifungal Resistance among Candida Species from Patients with Genitourinary Tract Infection Isolated in Benin City, Edo estate, Nigeria,” African Journal of Microbiology Research, Vol. 3, No. 11, 2009, pp. 694-699.
[13]	M. Richardson and D. Warnock, “Fungal Infection, Diagnosis and Treatment,” 3rd Edition, Blackwell Publishing, London, 2003, pp. 38-43.
[14]	C. Bii, T. Ouko, E. Amukoye and W. Githinji, “Antifungal Drug Susceptibility of Candida albicans,” East African Medical Journal, Vol. 79, No. 3, 2002, pp. 143-145. http://dx.doi.org/10.4314/eamj.v79i3.8894
[15]	K. Abu-Elteen and W. Abdul Malek, “Prevalence and Susceptibility of Vaginal Yeast Isolates in Jordan,” Mycoses, Vol. 40, No. 5-6, 1997, pp. 179-185. http://dx.doi.org/10.1111/j.1439-0507.1997.tb00211.x
[16]	J. Hollandia and M. Young, “Vulvovaginal Carriage of Yeasts Other Than Candida albicans,” Sexual Transmission Infections, Vol. 79, No. 3, 2003, p. 249. http://dx.doi.org/10.1136/sti.79.3.249 s
[17]	A. Spinillo, L. Colonna and G. Piazzi, “Prevalence of and Risk Factors for Fungal Vaginitis caused by Non-Albicans Species,” American Journal of Obstetrics and Gynecology, Vol. 176, No. 1,1997, pp. 138-141. http://dx.doi.org/10.1016/S0002-9378(97)80026-9
[18]	P. Nyirjesey, H. Grody and C. Jordan, “Chronic Fungal Vaginitis: The Value of Cultures,” American Journal of Obstetrics and Gynecology, Vol. 173, No. 3, 1995, pp. 820-823. http://dx.doi.org/10.1016/0002-9378(95)90347-X
[19]	G. Moran, D. Sullivan and D. Coleman, “Emergence of Non-Candida albicans Species as Pathogens in Candidiasis,” American Society for Microbiology, Washington DC, 2003, pp. 37-53.
[20]	H. Kent, “Epidemiology of Vaginitis,” American Journal of Obstetrics and Gynecology, Vol. 165, No. 4, 1991, pp. 1168-1176. http://dx.doi.org/10.1016/S0002-9378(12)90722-X
[21]	J. Sobel, “Epidemiology and Pathogenesis of Recurrent Vulvovaginal Candidiasis,” American Journal of Obstetrics and Gynecology, Vol. 152, 2000, pp. 924-935. http://dx.doi.org/10.1016/S0002-9378(85)80003-X
[22]	L. Otero, A. Fleiter and F. Mendez, “Susceptibility of Candida Species Isolated from Female prostitutes with Vulvovaginitis to Antifungal Agents and Boric Acid,” European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, No. 1, 1998, pp. 59-61. http://dx.doi.org/10.1007/s100960050227
[23]	N. Barg, “An introduction to Molecular Epidemiology,” Infection Control Hospital Epidemiology, Vol. 14, No. 7, 2003, pp. 395-396. http://dx.doi.org/10.1086/646768
[24]	S. El-Din, M. Reynolds, H. Astibee, R. Barton and G. Evan, “An Investigation into Pathogenesis of Vulvovaginal Candidiasis,” Sexual transmitted Infection, Vol. 77, No. 3, 2001, pp. 179-183. http://dx.doi.org/10.1136/sti.77.3.179
[25]	C. Le and J. Boen, “Health and Numbers: Basic Biostatistician Methods,” John Wiley, Chichester, 1995, pp. 178-198.
[26]	P. Feyi and A. Amadi, “The Prevalence and Pattern of Vaginal Candidiasis in Pregnancy in Abia,” Journal of Medical Investigation and Practice, Vol. 2, 2001, pp. 25-27.